Location: Rotterdam, Netherlands
Start Date: 3/21/2017
End Date: 3/22/2017
AllSeq Discount Code:asq/mp/15 (15%)
As part of its worldwide microbiome series, Global Engage is pleased to announce the 5th Microbiome R&D and Business Collaboration Forum: Europe which will be held on 21-22 March, 2018 and will be co-located with the 2nd Probiotics Congress: Europe.
This year’s event features 50+ presentations, 7 roundtable debates and an extended panel discussion on microbiome businesses and growth. Designed for those working across all areas of microbiota R&D, product development and funding, there’s something for everyone, so please take a look at the agenda.
As an AllSeq visitor, you can save 15% on the registration fee with discount code: asq/mp/15. But with over 90% of attendees saying they’d come again this year, places are sure to sell fast.
Last year’s congress attracted over 330 industry, academic and investment leaders to discuss the microbiome in health and disease; challenges and opportunities in moving research towards commercialisation; and potential partnerships and collaborations.
Over 370 attendees are expected to converge on Rotterdam to hear a 70-strong speaker faculty discuss the latest developments in microbiome research; engage in expert-led roundtable discussions and extended panel discussions; analyse the newest biotechs and start-ups worthy of investment; and utilise over seven hours of dedicated networking time to broaden business connections within the field. The Global Engage series is rapidly gaining a fantastic reputation as the number one microbiome networking event. If looking to either learn more from the top scientists in the microbiome and probiotic space; showcase exciting developments in your research; or seek partnerships and funding within the industry; it is a congress not to be missed.
• +60 presentations from industry and academic leaders
• +7 hours of dedicated networking time
• 5 expert-led roundtable discussions
• 5 extended senior-level interactive panel discussions
• Showcasing the latest start-ups and investment opportunities